bmiMD vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: bmiMD scores higher on our rubric, 8.0/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.
bmiMD beats MEDVi overall, scoring 8/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: bmiMD is $289/mo month-to-month; MEDVi is $179 first month, then $299/mo. Choose bmiMD for users who want an established, large-scale platform with same-day consults and strong promo pricing. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.
A side-by-side look at bmiMD and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
bmiMD
#4 of 54Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.
Visit bmiMDMEDVi
#46 of 54MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | bmiMD | MEDVi |
|---|---|---|
| Why each one | One of the largest GLP-1 telehealth platforms (80,000+ customers) with same-day physician consults and a money-back eligibility guarantee. | Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication. |
| Our Score | 8/10 | 5.7/10 |
| Headline Price | $289/mo month-to-month | $179 first month, then $299/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want an established, large-scale platform with same-day consults and strong promo pricing | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #4 | #46 |
| Get started | Visit bmiMD | Visit MEDVi |
Pros & Cons Compared
bmiMD
Pros
- +Same-day physician consults, one of the few platforms offering telehealth appointments the same day you apply
- +80,000+ customer base with a 4.3-star Trustpilot rating (600+ reviews) provides real social proof of reliability
- +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
- +HSA/FSA accepted for all programs
Cons
- −Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down
- −$29.99 shipping fee per order where most competitors ship free; factor it into your monthly total
- −A $50 non-refundable cancellation fee applies after intake approval; decide before the consult, and cancel at least 48 hours ahead of your monthly processing date
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
bmiMD edges out MEDVi with a score of 8/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: bmiMD is $289/mo month-to-month; MEDVi is $179 first month, then $299/mo.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving bmiMD and MEDVi.
- bmiMD vs Noom Med$79 first month, then $199/mo
- bmiMD vs Lemonaid Healthpublished $129/mo; total not verified
- bmiMD vs WeightWatchers (Sequence)$74/mo membership + medication
- MEDVi vs Oak Longevityfrom $119/mo
- MEDVi vs Fridays$249/mo month-to-month
- MEDVi vs Eden Health GLP-1from $249/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: bmiMD · 8.0/10